These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7921964)

  • 1. T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
    Champlin R
    J Hematother; 1993; 2(1):27-42. PubMed ID: 7921964
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
    Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
    Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
    [No Abstract]   [Full Text] [Related]  

  • 3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
    Champlin R; Jansen J; Ho W; Gajewski J; Nimer S; Lee K; Territo M; Winston D; Tricot G; Reichert T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1695-6. PubMed ID: 1899162
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
    Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
    J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
    Storb R; Appelbaum F; Buckner CD; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():80-4. PubMed ID: 2117976
    [No Abstract]   [Full Text] [Related]  

  • 9. [The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease].
    Choufi B; Thiant S; Trauet J; Cliquennois M; Cherrel M; Boulanger F; Coiteux V; Magro L; Labalette M; Yakoub-Agha I
    Pathol Biol (Paris); 2014 Jun; 62(3):123-8. PubMed ID: 24906571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.
    Trigg ME; Sondel PM; Billing R; Finlay JL; Peterson A; Hong R; Frierdich S; Shahidi N
    J Biol Response Mod; 1985 Dec; 4(6):602-12. PubMed ID: 3910764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
    Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
    Tiberghien P; Hervé P
    Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
    [No Abstract]   [Full Text] [Related]  

  • 14. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of allogeneic bone marrow cells: experimental investigations on the role of cell dose, graft-versus-host reactive T cells and pretransplant immunosuppression.
    Uharek L; Glass B; Gassmann W; Eckstein V; Steinmann J; Loeffler H; Mueller-Ruchholtz W
    Transplant Proc; 1992 Dec; 24(6):3023-5. PubMed ID: 1466042
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
    N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
    de Witte T; Preijers F; Schattenberg A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
    Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
    Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T cell depletion for allogeneic bone marrow transplantation].
    Morishima Y
    Nihon Rinsho; 1990 Sep; 48(9):1971-6. PubMed ID: 2232199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.